Related Experiment Video
Updated: Jun 25, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Factors associated with risk analysis for asymptomatic left ventricular diastolic dysfunction in nondialysis patients
Yajuan Gao1, Shengnan Chen1, Jiani Fu1
1Department of Nephrology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Over 92% of patients with chronic kidney disease (CKD) have asymptomatic left ventricular diastolic dysfunction (ALVDD). Age, diabetic nephropathy, hypertension, CKD stage, blood pressure, urinary protein, and low calcium are key risk factors for ALVDD.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Heart failure (HF) is a significant predictor of outcomes in chronic kidney disease (CKD) patients.
- Left ventricular diastolic dysfunction (LVDD) is a common cause of HF with preserved ejection fraction (HFpEF) in CKD.
- Identifying risk factors for LVDD is crucial for managing cardiovascular disease (CVD) in CKD.
Purpose of the Study:
- To determine the prevalence of asymptomatic left ventricular diastolic dysfunction (ALVDD) in nondialysis CKD patients.
- To identify clinical and demographic factors associated with ALVDD in this population.
Main Methods:
- Retrospective cross-sectional study involving 339 nondialysis CKD patients.
- Collection of clinical and echocardiographic data.
- Multivariate logistic regression analysis to identify risk factors for ALVDD.
Main Results:
- A high prevalence of ALVDD (92.04%) was observed in the study cohort.
- Factors associated with increased risk for ALVDD include older age, diabetic nephropathy, hypertensive nephropathy, advanced CKD stage, elevated mean arterial pressure, and increased urinary protein.
- Low blood calcium was associated with a reduced risk of ALVDD.
Conclusions:
- Asymptomatic left ventricular diastolic dysfunction is highly prevalent in nondialysis CKD patients.
- Close monitoring and management of age, hypertension, diabetes, CKD progression, proteinuria, and calcium levels are essential.
- Early detection and intervention for ALVDD may help prevent progression to symptomatic HF and improve cardiovascular outcomes in CKD patients.
More Related Videos
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Heart Failure Drugs: Diuretics
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

